Characterization
of materials with biological applications and
assessment of physiological effects of therapeutic interventions are
critical for translating research to the clinic and preventing adverse
reactions. Analytical techniques typically used to characterize targeted
nanomaterials and tissues rely on bulk measurement. Therefore, the
resulting data represent an average structure of
the sample, masking stochastic (randomly generated) distributions
that are commonly present. In this Perspective, we examine almost
20 years of work our group has done in different fields to characterize
and control distributions. We discuss the analytical techniques and
statistical methods we use and illustrate how we leverage them in
tandem with other bulk techniques. We also discuss the challenges
and time investment associated with taking such a detailed view of
distributions as well as the risks of not fully appreciating the extent
of heterogeneity present in many systems. Through three case studies
showcasing our research on conjugated polymers for drug delivery,
collagen in bone, and endogenous protein nanoparticles, we discuss
how identification and characterization of distributions, i.e., a
molecular view of the system, was critical for understanding the observed
biological effects. In all three cases, data would have been misinterpreted
and insights missed if we had only relied upon spatially averaged
data. Finally, we discuss how new techniques are starting to bridge
the gap between bulk and molecular level analysis, bringing more opportunity
and capacity to the research community to address the challenges of
distributions and their roles in biology, chemistry, and the translation
of science and engineering to societal challenges.